B2M and chronic kidney disease: The diagnostic performance of serum creatinine, cystatin C, and β2M was assessed using ROC curve analysis at a predefined eGFR threshold of 30 mL/min per 1.73 m2 to distinguish between moderate (CKD stage 3) and severe (CKD stage 4) kidney dysfunction.